Lyell Immunopharma, Inc. - Common Stock — Liquidità (NASDAQ:LYEL) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -126.25 M-169.56 M-163.69 M-162.39 M-150.02 M -133.8 M Flussi di cassa derivanti dalle attività di investimento -121.57 M-11.54 M184.05 M122.42 M54.1 M 2.01 M Liquidità derivante dalle attività di finanziamento 401.24 M10.63 M1.74 M1.33 M50.41 M 102.13 M Liquidità libera -126.25 M-169.56 M-163.69 M-162.39 M-150.8 M -134.42 M

Notizie

Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript

Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Lyell Immunopharma (LYEL)

Baird avvia la copertura su Lyell Immunopharma con rating outperform

BofA conferma Underperform su Lyell Immunopharma dopo uscita rivale

Lyell Immunopharma, Inc. (LYEL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

A First Look At Lyell Immunopharma (NASDAQ:LYEL)

Lyell Immunopharma Stock (LYEL) Slides Despite Praise from a Top Wall Street Analyst - TipRanks.com

Morning News Wrap-Up 4/10/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Lyell Immunopharma: Strong Early CAR-T Data, And Now A More Measured Bet (NASDAQ:LYEL)

H.C. Wainwright conferma il rating buy su Lyell Immunopharma

Citizens conferma il rating su Lyell Immunopharma per i progressi degli studi

Citizens reiterates Lyell Immunopharma stock rating on trial progress